IPO Boutique

Inozyme Pharma, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...



For IPO Boutique's "scale of 1 to 5" BUY rating on Inozyme Pharma, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Inozyme Pharma, Inc.INZY -
NASDAQ
$16.00-$16.00 $16.00 $20.857 million7/24/2020
BofA Securities, Cowen, Piper Sandler
Co-Manager(s):
Wedbush PacGrow
Health Care
Filing(s):

Filed 2020-07-02
Terms Added 2020-07-20
Amended Terms 2020-07-23



Inozyme Pharma, Inc. Quote & Chart - Click for current quote - INZY

About Inozyme Pharma, Inc. (adapted from Inozyme Pharma, Inc. prospectus):
They are a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "INZY" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved